Nplate 500 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBM6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,339
Award facts
- Contract value 100% obligated
- $27,339.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) issued a delivery order valued at $27,339.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 500 mcg vials of Nplate. The order was awarded on November 24, 2025, under a firm fixed-price contract type with an ultimate completion date of December 16, 2025. No set-aside designation was applied to this award, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will occur at the vendor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support Department of Defense medical supply needs worldwide. The IDC, designated contract SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, with a completion date of December 31, 2036, and includes a 30-month base period with three optional 30-month renewal periods. Through this vehicle, DMS Pharmaceutical Group serves as a critical pharmaceutical supplier enabling DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables supporting military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DR26FFBM6?
SPE2DR26FFBM6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FFBM6 worth?
The government has obligated $27,339 on SPE2DR26FFBM6.
Is contract SPE2DR26FFBM6 an order under another contract?
Yes. SPE2DR26FFBM6 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBM6 competed?
The extent of competition for SPE2DR26FFBM6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award